Home
Categories
EXPLORE
True Crime
Comedy
Business
Society & Culture
Health & Fitness
Sports
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Podjoint Logo
US
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts123/v4/a0/a1/29/a0a129bb-c88a-c65c-5f0a-774df88dd07a/mza_17969811586559349542.jpg/600x600bb.jpg
Tech on Drugs with Shai Shen-Orr
CytoReason
12 episodes
2 months ago
In a big-data age, drug development needs to be reinvented. The data revolution is already taking place in finance and commerce, in agriculture and transportation. There’s no reason for pharma to stay behind. “Tech on Drugs” is a podcast about the future of pharma. From novel targets to novel biomarkers. From disease models to population models. From clinical trials to synthetic trials.

It’s a show about the doctor in the clinic who needs to build on molecular features and about the bioinformatician in the lab who needs to build on clinical endpoints. In each episode, our host, Prof. Shai Shen-Orr, gets to do what he loves to do most. He gets to speak with some of the world’s top scientists and healthcare executives about the industry's digital transformation.
Show more...
Technology
RSS
All content for Tech on Drugs with Shai Shen-Orr is the property of CytoReason and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In a big-data age, drug development needs to be reinvented. The data revolution is already taking place in finance and commerce, in agriculture and transportation. There’s no reason for pharma to stay behind. “Tech on Drugs” is a podcast about the future of pharma. From novel targets to novel biomarkers. From disease models to population models. From clinical trials to synthetic trials.

It’s a show about the doctor in the clinic who needs to build on molecular features and about the bioinformatician in the lab who needs to build on clinical endpoints. In each episode, our host, Prof. Shai Shen-Orr, gets to do what he loves to do most. He gets to speak with some of the world’s top scientists and healthcare executives about the industry's digital transformation.
Show more...
Technology
https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/8650374187e5f4648bd81c4c645eb22e.jpg
Tech On Drugs - Se2Ep4 - Dr. Tom Bumol
Tech on Drugs with Shai Shen-Orr
43 minutes
11 months ago
Tech On Drugs - Se2Ep4 - Dr. Tom Bumol
Tom Bumol's career spans major roles at Eli Lilly, the Allen Institute, and beyond. He is also a distinguished member of CytoReason's Science Advisory Board.In this episode, Tom shares insights into drug development's successes, failures, and future direction, including:
  • Lessons from lupus - the story of a failed lupus trial that revealed the critical importance of understanding disease heterogeneity and inspired new approaches in immunology.
  • From trial and error to predictability - how AI and systems biology can transform drug development by embracing human complexity.
  • Combination therapies and beyond - designing drugs with precision to improve patient outcomes and broaden therapeutic reach.
All this and much more in a captivating discussion with our Chief Scientist Shai Shen-Orr. Enjoy!
Tech on Drugs with Shai Shen-Orr
In a big-data age, drug development needs to be reinvented. The data revolution is already taking place in finance and commerce, in agriculture and transportation. There’s no reason for pharma to stay behind. “Tech on Drugs” is a podcast about the future of pharma. From novel targets to novel biomarkers. From disease models to population models. From clinical trials to synthetic trials.

It’s a show about the doctor in the clinic who needs to build on molecular features and about the bioinformatician in the lab who needs to build on clinical endpoints. In each episode, our host, Prof. Shai Shen-Orr, gets to do what he loves to do most. He gets to speak with some of the world’s top scientists and healthcare executives about the industry's digital transformation.